Huntington Bancshares Incorporated (HBAN), the Columbus, Ohio-based regional bank holding company with a market capitalization of approximately $35 billion, has drawn growing attention from investors searching for value in the financial sector. With the stock trading near $17.35 and a 52-week range of $14.89 to $19.45, the $25 price target has surfaced in investor discussions as a psychologically significant round number that would represent the stock's highest level in over two decades. The question is whether the fundamental and technical building blocks exist to support such a move.
Huntington Bancshares currently trades at a trailing price-to-earnings (P/E) ratio of approximately 13.4, with a forward P/E near 11.4 based on 2026 earnings estimates of $1.62 per share. The stock offers a dividend yield of roughly 3.56%, providing an income component that regional bank investors typically value. Institutional ownership stands above 80%, reflecting broad professional confidence in the bank's strategy. Major holders have been actively adding to positions, with firms such as CIBC Asset Management increasing their stake by 24.5% and HSBC Holdings boosting its position by 25.4% in recent quarters.
The bank's recent performance lends credibility to the bullish narrative. First-quarter 2026 adjusted earnings per share (EPS) of $0.37 beat consensus estimates of $0.36, driven by a 36% year-over-year increase in adjusted pre-provision net revenue (PPNR). Commercial loan growth expanded 21.3% year-over-year to $87.1 billion, accounting for the lion's share of the $17.3 billion increase in earning assets. Core deposit growth, excluding the Cadence acquisition, added $3.8 billion sequentially in the first quarter alone.
Several catalysts could propel HBAN toward the $25 target over the next two to three years. The board's approval of a new $3 billion share repurchase program in April 2026 signals management's confidence in the bank's capital position and intrinsic value. The company has already retired approximately 15 million shares year-to-date under existing authorizations, and continued buybacks at current valuations would be accretive to EPS.
Management's 2027 profitability targets provide a roadmap: EPS of $1.90 to $1.93 and return on tangible common equity (ROTCE) of 18% to 19%. Achieving those targets would put the stock at roughly 13 times forward earnings at $25, a multiple that remains reasonable within the regional banking sector. Additionally, the Basel III Endgame framework is modeled to reduce risk-weighted assets by approximately 7.5% to 8%, potentially freeing up an estimated 80 basis points of Common Equity Tier 1 (CET1) capital for deployment.
The macroeconomic backdrop could also provide tailwinds. A "higher for longer" interest rate environment, while pressuring near-term NIM, ultimately benefits well-capitalized regional banks with diversified loan books. Huntington's growing commercial banking presence in the Southeast and Texas, enhanced by the Cadence acquisition, positions it to capture market share in faster-growing regions.
The path to $25 is not without significant obstacles. Management has already guided 2026 NIM toward the high 3.20% range, down from a prior expectation of mid-3.30%, partly due to a deliberate $4 billion liquidity build in Federal Reserve cash. While prudent, this drags on near-term profitability. Jefferies downgraded the stock to Hold in July 2026, citing persistent near-term headwinds and a "lingering" M&A-related discount that could continue weighing on valuation multiples relative to peers.
Any economic downturn that pressures credit quality in Huntington's commercial loan portfolio—particularly in commercial real estate (CRE), where the bank has deliberately reduced construction exposure—could derail the earnings trajectory needed to justify a $25 valuation. Furthermore, if the Federal Reserve cuts rates more aggressively than expected, deposit repricing benefits may diminish faster than loan yields adjust, squeezing margins.
Wall Street maintains a broadly constructive but measured outlook on HBAN. Of 20 analysts covering the stock, 14 rate it Buy or Strong Buy, five rate it Hold, and one rates it Sell, yielding a consensus rating of Moderate Buy. The average 12-month price target stands at approximately $20.25, with a range spanning from $18.00 to $23.00. UBS holds the Street-high target at $22, while firms including Morgan Stanley, RBC Capital, and Evercore ISI have targets at $21. Notably, a $25 price target would exceed every published analyst forecast, requiring the stock to trade above the highest current Wall Street projection by roughly 9%.
From a technical perspective, the stock faces immediate overhead resistance at the 52-week high of $19.45. A breakout above that level would put the psychologically important $20 mark in play—a level the stock has not sustainably traded above in recent history. On the downside, the 200-day moving average near $16.74 and the 50-day moving average around $16.62 provide the first layers of support, with the 52-week low of $14.89 representing the critical floor. To reach $25, the stock would need to clear $19.45, then $20, and then build a new base above those levels before mounting a run toward the mid-$20s—a process that would likely unfold over multiple quarters, not weeks.
Traders seeking real-time guidance on stocks like Huntington Bancshares can turn to Tickeron's AI Daily Buy/Sell Signals, a tool that uses artificial intelligence to continuously monitor thousands of stocks and ETFs. The system generates Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis, helping traders uncover opportunities, manage existing positions, and identify shifting market trends with greater efficiency. For those navigating the complex regional banking landscape, AI-powered signals offer a data-driven complement to traditional fundamental and technical research.
Can Huntington Bancshares realistically reach $25? The answer depends on time horizon and execution. Over a 12-month window, the target appears aggressive—it sits well above every analyst forecast and would require a nearly 45% advance from current levels, far exceeding the consensus upside of roughly 17%. Over a two-to-three-year horizon, however, the math becomes more plausible. If management delivers on its 2027 EPS target of approximately $1.92 and the market assigns a modest multiple of 13 times those earnings, the stock would trade right at $25. Achieving this would require continued commercial loan growth, successful integration of the Cadence franchise, disciplined expense management, and a macroeconomic environment that avoids a credit cycle downturn. Investors should monitor quarterly NIM trends, loan loss provisions, and progress toward the 2027 ROTCE target as the most reliable indicators of whether the path to $25 remains intact.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HBAN has been closely correlated with FITB. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if HBAN jumps, then FITB could also see price increases.
| Ticker / NAME | Correlation To HBAN | 1D Price Change % | ||
|---|---|---|---|---|
| HBAN | 100% | -1.04% | ||
| FITB - HBAN | 88% Closely correlated | -1.05% | ||
| PNC - HBAN | 85% Closely correlated | -0.29% | ||
| KEY - HBAN | 85% Closely correlated | -0.98% | ||
| MTB - HBAN | 84% Closely correlated | +0.08% | ||
| CFG - HBAN | 84% Closely correlated | -1.23% | ||
More | ||||
| Ticker / NAME | Correlation To HBAN | 1D Price Change % |
|---|---|---|
| HBAN | 100% | -1.04% |
| HBAN (101 stocks) | 73% Closely correlated | -0.93% |
| Regional Banks (360 stocks) | 71% Closely correlated | -0.62% |
| Banks (433 stocks) | 68% Closely correlated | -0.75% |